WO2022192529A1 - Activation de zymogènes par des enzymes protéases immobilisées - Google Patents
Activation de zymogènes par des enzymes protéases immobilisées Download PDFInfo
- Publication number
- WO2022192529A1 WO2022192529A1 PCT/US2022/019738 US2022019738W WO2022192529A1 WO 2022192529 A1 WO2022192529 A1 WO 2022192529A1 US 2022019738 W US2022019738 W US 2022019738W WO 2022192529 A1 WO2022192529 A1 WO 2022192529A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- transglutaminase
- protease
- immobilized
- activated
- tgase
- Prior art date
Links
- 108091005804 Peptidases Proteins 0.000 title claims abstract description 91
- 102000010911 Enzyme Precursors Human genes 0.000 title claims abstract description 47
- 108010062466 Enzyme Precursors Proteins 0.000 title claims abstract description 47
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title claims abstract 20
- 230000004913 activation Effects 0.000 title description 9
- 239000004365 Protease Substances 0.000 claims abstract description 88
- 108060008539 Transglutaminase Proteins 0.000 claims abstract description 72
- 102000003601 transglutaminase Human genes 0.000 claims abstract description 72
- 238000000034 method Methods 0.000 claims abstract description 28
- 230000003213 activating effect Effects 0.000 claims abstract description 6
- 230000000813 microbial effect Effects 0.000 claims description 16
- 230000001580 bacterial effect Effects 0.000 claims description 14
- 108090000787 Subtilisin Proteins 0.000 claims description 7
- 230000002538 fungal effect Effects 0.000 claims description 6
- 101000837751 Streptomyces mobaraensis Protein-glutamine gamma-glutamyltransferase Proteins 0.000 claims description 5
- 102000035195 Peptidases Human genes 0.000 description 71
- 235000019419 proteases Nutrition 0.000 description 53
- 108090000623 proteins and genes Proteins 0.000 description 39
- 102000004169 proteins and genes Human genes 0.000 description 36
- 235000018102 proteins Nutrition 0.000 description 34
- 230000000694 effects Effects 0.000 description 29
- 239000000047 product Substances 0.000 description 22
- 102000004190 Enzymes Human genes 0.000 description 21
- 108090000790 Enzymes Proteins 0.000 description 21
- 229940088598 enzyme Drugs 0.000 description 21
- 150000001413 amino acids Chemical class 0.000 description 20
- 108090000765 processed proteins & peptides Proteins 0.000 description 17
- 229940024606 amino acid Drugs 0.000 description 14
- 235000001014 amino acid Nutrition 0.000 description 14
- 239000000758 substrate Substances 0.000 description 14
- 239000006166 lysate Substances 0.000 description 13
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 11
- 150000007523 nucleic acids Chemical class 0.000 description 11
- 239000000463 material Substances 0.000 description 10
- 102000004196 processed proteins & peptides Human genes 0.000 description 10
- 238000003556 assay Methods 0.000 description 9
- 102000039446 nucleic acids Human genes 0.000 description 9
- 108020004707 nucleic acids Proteins 0.000 description 9
- 238000001994 activation Methods 0.000 description 8
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- -1 conditioner Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 125000000539 amino acid group Chemical group 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 239000004472 Lysine Substances 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- 241001495137 Streptomyces mobaraensis Species 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 239000000645 desinfectant Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 235000019833 protease Nutrition 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 238000004611 spectroscopical analysis Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 108010076119 Caseins Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- 108010093096 Immobilized Enzymes Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 102000005741 Metalloproteases Human genes 0.000 description 2
- 108010006035 Metalloproteases Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- 108010022999 Serine Proteases Proteins 0.000 description 2
- 102000012479 Serine Proteases Human genes 0.000 description 2
- 108010056079 Subtilisins Proteins 0.000 description 2
- 102000005158 Subtilisins Human genes 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 108010007093 dispase Proteins 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 108010003855 mesentericopeptidase Proteins 0.000 description 2
- 108010020132 microbial serine proteinases Proteins 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 108010011619 6-Phytase Proteins 0.000 description 1
- 108010013043 Acetylesterase Proteins 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- ZHQQRIUYLMXDPP-SSDOTTSWSA-N Actinidine Natural products C1=NC=C(C)C2=C1[C@H](C)CC2 ZHQQRIUYLMXDPP-SSDOTTSWSA-N 0.000 description 1
- 102000057234 Acyl transferases Human genes 0.000 description 1
- 108700016155 Acyl transferases Proteins 0.000 description 1
- 101710152845 Arabinogalactan endo-beta-1,4-galactanase Proteins 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- 108091005504 Asparagine peptide lyases Proteins 0.000 description 1
- 108091005502 Aspartic proteases Proteins 0.000 description 1
- 102000035101 Aspartic proteases Human genes 0.000 description 1
- 239000007989 BIS-Tris Propane buffer Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108700038091 Beta-glucanases Proteins 0.000 description 1
- 102100032487 Beta-mannosidase Human genes 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 108010008885 Cellulose 1,4-beta-Cellobiosidase Proteins 0.000 description 1
- 108010023736 Chondroitinases and Chondroitin Lyases Proteins 0.000 description 1
- 102000011413 Chondroitinases and Chondroitin Lyases Human genes 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- 102000005927 Cysteine Proteases Human genes 0.000 description 1
- 206010012444 Dermatitis diaper Diseases 0.000 description 1
- 208000003105 Diaper Rash Diseases 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- 101710147028 Endo-beta-1,4-galactanase Proteins 0.000 description 1
- 101710111935 Endo-beta-1,4-glucanase Proteins 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 241001302160 Escherichia coli str. K-12 substr. DH10B Species 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010091443 Exopeptidases Proteins 0.000 description 1
- 102000018389 Exopeptidases Human genes 0.000 description 1
- 108090000270 Ficain Proteins 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 108050008938 Glucoamylases Proteins 0.000 description 1
- 108091005503 Glutamic proteases Proteins 0.000 description 1
- 238000010268 HPLC based assay Methods 0.000 description 1
- 108050009363 Hyaluronidases Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000003820 Lipoxygenases Human genes 0.000 description 1
- 108090000128 Lipoxygenases Proteins 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- 102100036617 Monoacylglycerol lipase ABHD2 Human genes 0.000 description 1
- 108010049190 N,N-dimethylcasein Proteins 0.000 description 1
- 108091005461 Nucleic proteins Chemical group 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 102100030944 Protein-glutamine gamma-glutamyltransferase K Human genes 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 108091005501 Threonine proteases Proteins 0.000 description 1
- 102000035100 Threonine proteases Human genes 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 108010027199 Xylosidases Proteins 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- ZHQQRIUYLMXDPP-ZETCQYMHSA-N actinidine Chemical compound C1=NC=C(C)C2=C1[C@@H](C)CC2 ZHQQRIUYLMXDPP-ZETCQYMHSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 108700014220 acyltransferase activity proteins Proteins 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108010030291 alpha-Galactosidase Proteins 0.000 description 1
- 102000005840 alpha-Galactosidase Human genes 0.000 description 1
- 108010084650 alpha-N-arabinofuranosidase Proteins 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 108010009043 arylesterase Proteins 0.000 description 1
- 102000028848 arylesterase Human genes 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 108010019077 beta-Amylase Proteins 0.000 description 1
- 108010055059 beta-Mannosidase Proteins 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
- HHKZCCWKTZRCCL-UHFFFAOYSA-N bis-tris propane Chemical compound OCC(CO)(CO)NCCCNC(CO)(CO)CO HHKZCCWKTZRCCL-UHFFFAOYSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001876 chaperonelike Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 108010005400 cutinase Proteins 0.000 description 1
- 125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical compound CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940066758 endopeptidases Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000019836 ficin Nutrition 0.000 description 1
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 108010007119 flavourzyme Proteins 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 108010059345 keratinase Proteins 0.000 description 1
- 108010062085 ligninase Proteins 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 108010009355 microbial metalloproteinases Proteins 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- MLEBFEHOJICQQS-UHFFFAOYSA-N monodansylcadaverine Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(=O)(=O)NCCCCCN MLEBFEHOJICQQS-UHFFFAOYSA-N 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000012771 pancakes Nutrition 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 108010087558 pectate lyase Proteins 0.000 description 1
- 108010072638 pectinacetylesterase Proteins 0.000 description 1
- 102000004251 pectinacetylesterase Human genes 0.000 description 1
- 238000010419 pet care Methods 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000734 protein sequencing Methods 0.000 description 1
- 108010056534 proteinase T Proteins 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 102220162858 rs369457258 Human genes 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000007480 sanger sequencing Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 244000000000 soil microbiome Species 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 108010038851 tannase Proteins 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940100611 topical cream Drugs 0.000 description 1
- 238000007056 transamidation reaction Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
- 108010083879 xyloglucan endo(1-4)-beta-D-glucanase Proteins 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/104—Aminoacyltransferases (2.3.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/02—Aminoacyltransferases (2.3.2)
- C12Y203/02013—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Definitions
- Immobilized enzymes are typically more robust and more resistant to environmental changes compared to free enzymes in solution. More importantly, the heterogeneity of immobilized enzyme systems allows an easy or more simplified recovery of both enzymes and products, multiple re-use of enzymes, continuous operation of enzymatic processes, rapid termination of reactions, and greater variety of bioreactor designs.
- a method for activating a zymogen of a transglutaminase comprising contacting the zymogen with at least one immobilized protease to produce an active form of transglutaminase and, optionally, separating the activated transglutaminase from the immobilized protease.
- an activated transglutaminase produced by contacting a zymogen with at least one immobilized protease to produce an active form of transglutaminase and, optionally, separating the activated transglutaminase from the immobilized protease.
- the transglutaminase is a microbial transglutaminase.
- the microbial transglutaminase is a Streptomyces mobaraensis transglutaminase or a variant thereof.
- the at least one immobilized protease is selected from the group consisting of bacterial proteases and fungal proteases.
- the bacterial protease is subtilisin.
- FIG. 1 shows SDS-PAGE analysis of S. mobarensis Tgase, as described in Example 2. Lane 1 - mature Tgase; Lane 2 - zymogen (pro-Tgase); Lane 3 - clarified lysate containing zymogen (crude pro-Tgase); Lane 4 - clarified lysate treated with immobilized protease for 60 minutes; Lane L - protein ladder. Expected molecular weight of the zymogen (pro-Tgase) is 43.6 kDa and the expected molecular weight of the mature Tgase is 38.9 kDa.
- composition or the specified steps of a methods, and those additional materials or steps that do not materially affect the basic characteristics of the material or method.
- Optional or “optionally” means that the subsequently described event, circumstance, or material may or may not occur or be present, and that the description includes instances where the event, circumstance, or material occurs or is present and instances where it does not occur or is not present.
- zymogen refers to an inactive precursor of an enzyme, which may be converted into an active/activated or mature enzyme by catalytic action, such as via proteolytic cleavage of a pro-sequence.
- a “pro-sequence” refers to a polypeptide sequence within an expressed protein, e.g., a zymogen, which is typically cleaved from the protein to produce an active protein, such as an enzyme.
- a pro-sequence may be essential for correct folding of the protein.
- cleavage of the pro-sequence results in transition of an inactive enzyme to active or activated enzyme.
- the terms "mature”, “active”, and activated” are used interchangeably herein.
- An activated form of a protein, polypeptide, or peptide refers to the functional form of the protein, polypeptide, or enzyme without a signal, silencing, or chaperoning propeptide sequence. Additionally, the mature enzyme may be truncated or extended relative to the mature sequence while maintaining the desired catalytic activity (e.g., cross-linking activity).
- T ransglutaminases are a family of enzymes that catalyze the formation of an isopeptide bond between a primary amine, for example, the e-amine of a lysine molecule, and the acyl group of a protein- or peptide-bound glutamine.
- Transglutaminases may catalyze a transamidation reaction between glutamyl and lysyl side chains of target proteins. Proteins possessing Tgase activity have been found in microorganisms, plants, and animals. Tgases are widely distributed in various organs, tissues, and bodily fluids.
- Tgases also form extensively cross-linked, generally insoluble, protein biopolymers that are needed for an organism to create barriers and stable structures.
- an “activated Tgase” is a Tgase having or capable of reacting with amino acids, peptides and/or proteins.
- Tgases of microbial origin are calcium- independent, which represents a major advantage for their practical use.
- Microbial transglutaminase (Tgase, EC 2.3.2.13) is one of the most extensively studied industrial enzymes for protein functionalization and protein cross-linking because of its ability to polymerize or functionalize proteins through the formation of a stable £-(y-glutamyl)lysine isopeptide bond without the constraint of a consensus sequence or additional cofactors.
- An “immobilized protease” refers to immobilization of a protease to/on a matrix or support.
- a “protease” (also called a peptidase or proteinase) refers to enzymes capable of cleaving peptide bonds.
- Proteases are any of various enzymes, such as endopeptidases and exopeptidases, that catalyze the hydrolytic breakdown of proteins into peptides and amino acids.
- Proteases can be classified into seven broad groups: serine proteases, cysteine proteases, threonine proteases, aspartic proteases, glutamic proteases, metalloproteases, and asparagine peptide lyases.
- Proteases can be found in animals, plants, bacteria, fungi, archaea, and viruses.
- the terms “protease, “peptidase”, and “proteinase” are used interchangeably herein.
- Subtilisin is a protease initially obtained from Bacillus subtilis.
- peptides are used interchangeably herein and refer to a polymer of amino acids joined together by peptide bonds.
- a “protein” or “polypeptide” comprises a polymeric sequence of amino acid residues.
- the single and 3- letter code for amino acids as defined in conformity with the lUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN), well known to those skilled in the art, is used throughout this disclosure.
- the single letter X refers to any of the twenty amino acids. It is also understood that a polypeptide may be coded for by more than one nucleotide sequence due to the degeneracy of the genetic code.
- Mutations can be named by the one letter code for the parent amino acid, followed by a position number and then the one letter code for the variant amino acid.
- mutating glycine (G) at position 87 to serine (S) is represented as "G087S” or "G87S”.
- a position followed by amino acids listed in parentheses indicates a list of substitutions at that position by any of the listed amino acids.
- 6(L, I) means position 6 can be substituted with a leucine or isoleucine.
- a slash (/) is used to define substitutions, e.g., F/V, indicates that the position may have a phenylalanine or valine at that position.
- amino acid refers to the basic chemical structural unit of a protein, peptide, or polypeptide.
- corresponding to or “corresponds to” or “correspond to” or “corresponds” refers to an amino acid residue at the enumerated position in a protein or peptide, or an amino acid residue that is analogous, homologous, or equivalent to an enumerated residue in a protein or peptide.
- corresponding region generally refers to an analogous position in a related protein or a reference protein.
- variant proteins encompass “variant” or “mutant” proteins, which terms are used interchangeably herein.
- Variant proteins differ from another (/.e., parental) protein and/or from one another by a small number of amino acid residues.
- a variant may include one or more amino acid mutations (e.g., amino acid deletion, insertion or substitution) as compared to the parental protein from which it is derived.
- variants may have a specified degree of sequence identity with a reference protein or nucleic acid, e.g., as determined using a sequence alignment tool, such as BLAST, ALIGN, and CLUSTAL.
- variant proteins or nucleic acid may have at least about 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or even 99.5% amino acid sequence identity with a reference sequence and integer percentage therebetween [0036]
- wild-type in reference to an amino acid sequence or nucleic acid sequence indicates that the amino acid sequence or nucleic acid sequence is a native or naturally-occurring sequence.
- naturally-occurring refers to anything (e.g., proteins, amino acids, or nucleic acid sequences) that is found in nature.
- non-naturally occurring refers to anything that is not found in nature (e.g., recombinant/engineered nucleic acids and protein sequences produced in the laboratory or modification of the wild-type sequence).
- derived from encompasses the terms “originated from,” “obtained from,” “obtainable from,” “isolated from,” “purified from,” and “created from,” and generally indicates that one specified material finds its origin in another specified material or has features that can be described with reference to another specified material.
- isolated refers to a material (e.g., a protein, nucleic acid, or cell) that is removed from at least one component with which it is naturally associated.
- these terms may refer to a material which is substantially or essentially free from components which normally accompany it as found in its native state, such as, for example, an intact biological system.
- An isolated nucleic acid molecule includes a nucleic acid molecule contained in cells that ordinarily express the nucleic acid molecule, but the nucleic acid molecule is present extrachromosomally or at a chromosomal location that is different from its natural chromosomal location.
- a method for activating a zymogen of a transglutaminase comprising contacting the zymogen with at least one immobilized protease to produce an active form of transglutaminase and, optionally, separating the activated transglutaminase from the immobilized protease.
- the transglutaminase is a microbial Tgase
- the microbial Tgase is a bacterial transglutaminase, such as a Streptomyces Tgase
- the bacterial Tgase is from Streptomyces mobaraensis, or a variant thereof.
- Streptomyces mobaraensis belongs to a large group of Gram-positive, filamentous soil bacteria with a complex life cycle.
- Transglutaminase variants and methods of producing such variants are disclosed, for example, in PCT Publication Numbers WO 2016/170447, published on October 27, 2016, and WO 2019/094301 , published on May 16, 2019.
- zymogen of a transglutaminase requires cleavage of a pro-sequence from a zymogen form of the enzyme, resulting in mature, catalytically active enzyme.
- a zymogen of a Tgase is contacted with at least one immobilized protease to produce an activated form of a Tgase, and optionally, separating the activated Tgase from the immobilized protease.
- Any protease that produces an activated form of a Tgase from the zymogen of a Tgase may be used as described herein.
- Nonlimiting examples of proteases that may be immobilized for use in cleaving a pro-sequence from a Tgase as described herein include, but are not limited to, bacterial and fungal proteases.
- the bacterial protease is a subtilisin.
- trypsin proteinase K; proteinase T; Dispase® I; Dispase® II; Papain®; Bromelain®; Ficin®; Actinidine®; Protex 6L, Multifect® PR 6L; Protex® 7L, Multifect® PR 7L; Protex® 14L, Multifect® PR 14L; Protex® 15L, Multifect® PR 15L; Protex® 30L, Multifect® PR 30L; Protex® 40L, Optimase® PR 40L; Protex® 50FP, Multifect® PR 50G; Protex® 51 FP, Multifect® PR 51 G; Protex® 89L, Optimase® PR 89L, Alcalase®, Savinase®, Everlase®, Esperase®, Flavourzyme®, Neutrase®.
- immobilized proteases such as Alcalase®, Savinase®, Everlase®, or Esperase®, are commercially available as a protease pre-immobilized and conjugated to a support matrix.
- Conditions for contacting the zymogen of a Tgase with an immobilized protease include any conditions that are suitable for activity of a selected protease(s). Such conditions are readily ascertainable by one of skill in the art.
- Activated zymogens of any of the Tgases described herein may be used in a variety of applications such as, but not limited to, food, pharmaceutical, cosmetic, healthcare, marine, paint, coating, energy (e.g., fracking fluid), plastic, packaging, and agricultural products.
- the activated Tgase may be incorporated into HVAC systems, cooling ponds, water purification systems, or may be used in an industrial application, such as, but not limited to, pulp and paper processing.
- the activated zymogens of Tgases may be used in healthcare products, personal care or cosmetic formulations, packaging (food, cosmetic, and pharmaceuticals), textile and leather production, paints and coatings, and marine applications including water treatment and purification.
- the activated zymogens of Tgases may be employed for permanently modifying proteins of interest, by way of example keratin and collagen, with dyes or proteins.
- the activated zymogen of any of the Tgases described herein is included in a personal care product, such as, but not limited to, bar soap, liquid soap (e.g., hand soap), hand sanitizer (including rinse off and leave-on alcohol based and aqueous- based hand disinfectants), preoperative skin disinfectant, cleansing wipes, disinfecting wipes, body wash, acne treatment products, antifungal diaper rash cream, antifungal skin cream, shampoo, conditioner, cosmetics (including but not limited to liquid or powder foundation, liquid or solid eyeliner, mascara, cream eye shadow, tinted powder, "pancake” type powder to be used dry or moistened, make up removal products, etc.), deodorant, antimicrobial creams, body lotion, hand cream, topical cream, aftershave lotion, skin toner, mouth wash, toothpaste, sunscreen, and baby products such as, but not limited to, cleansing wipes, baby shampoo, baby soap, and diaper cream.
- a personal care product such as, but not limited to, bar soap, liquid soap (
- an activated zymogen of a Tgase may be included in a wound care item, such as, but not limited to, wound healing ointments, creams, and lotions, wound coverings, burn wound cream, bandages, tape, and steri-strips, and medical articles such as medical gowns, caps, face masks, and shoe-covers, surgical drops, etc.
- the activated zymogen, of any of the Tgases described herein may be included in an oral care product, such as mouth rinse, toothpaste, or dental floss coating, a veterinary or pet care product, a preservative composition, or a surface disinfectant, such as a disinfectant solution, spray or wipe.
- an oral care product such as mouth rinse, toothpaste, or dental floss coating
- a veterinary or pet care product such as a veterinary or pet care product
- a preservative composition such as a veterinary or pet care product
- a surface disinfectant such as a disinfectant solution, spray or wipe.
- a product or composition which includes an activated zymogen of any of the Tgases as described herein may further include one or more additional enzymes selected from acyl transferases, alpha-amylases, beta-amylases, alpha- galactosidases, arabinosidases, aryl esterases, beta-galactosidases, carrageenases, catalases, cellobiohydrolases, cellulases, chondroitinases, cutinases, endo-beta-1 ,4- glucanases, endo-beta-mannases, esterases, exo-mannanases, galactanases, glucoamylases, hemicellulases, hyaluronidases, keratinases, laccases, lactases, ligninases, lipases, lipoxygenases, mannanases,
- an activated zymogen of any of the Tgases described herein may be included in a product to be used for long-lasting application of functional ingredients including UV-blocking sunscreens, and/or coloring agents, such as pigments or dyes.
- such activated zymogens may be incorporated in a product to be applied topically and which bonds to the skin of an individual, such as a UV-blocking (sunscreen) product, or a cosmetic product.
- the activated zymogen may be used to provide permanent application of color to the skin of an animal such as in leather processing.
- the activated zymogen may be used to provide a permanent application of color in food processing.
- Non-limiting embodiments of the foregoing disclosed herein include: [0055] 1. A method for activating a zymogen of a transglutaminase, said method comprising contacting the zymogen with at least one immobilized protease to produce an active form of transglutaminase and, optionally, separating the activated transglutaminase from the immobilized protease.
- transglutaminase is a microbial transglutaminase.
- Streptomyces mobaraensis transglutaminase or a variant thereof.
- Three different assays can be used to assess activity of an activated Tgase derived from a zymogen of Tgase and activated using at least one immobilized protease as described herein.
- Transglutaminase activity was measured herein using a colorimetric hydroxamate activity assay (Folk and Cole (1965) J Biol Chemistry 240(7) :2951-2960). Briefly, the hydroxamate assay uses N-benzyloxycarbonyl-L-glutaminyl-glycine (ZQG) as a low molecular weight amine acceptor substrate and hydroxylamine as an amine donor. In the presence of transglutaminase, the hydroxylamine is incorporated to form Z- glutamylhydroxamate-glycine, which develops a colored complex with iron (III), detectable at 525 nm after incubation at 37 °C for 5-60 minutes.
- ZQG N-benzyloxycarbonyl-L-glutaminyl-glycine
- ZQG N-benzyloxycarbonyl-L-glutaminyl-glycine
- the hydroxylamine is incorporated to form Z- glutamylhydro
- Tgase L- glutamic acid g -monohydroxamate (Millipore Sigma) as standard.
- One unit of Tgase is defined as the amount of enzyme that catalyzes formation of 1 pmol of the peptide derivative of g-glutamylhydroxylamine per minute.
- Transglutaminase activity is monitored by measuring the fluorescence (excitation wavelength 332 nm; emission wavelength 500 nm) using a BioTek Synergy H1 microplate reader.
- Transglutaminase-catalyzed covalent coupling (crosslinking) of monodansylcadaverine with N,N-dimethylcasein (high molecular weight substrate) produces a product that causes a shift in intensity and wavelength of fluorescence of the dansyl group now linked to the casein.
- the relative transglutaminase activity is shown by increase of fluorescence intensity overtime.
- the samples are then run on an Agilent 1100 series HPLC through a Zorbax Eclipse Plus C18 column at 20-65% 0.08% TFA in Acetonitrile. Percent conversion of substrates to cross-linked product was calculated from the HPLC trace data to assess activity of the Tgase activated from a zymogen using at least one immobilized protease.
- the gene coding for the pro-Tgase was codon optimized for expression in E. coli based on the published amino acid sequence (Kanaji, et al. (1993) J. Biol. Chem.
- the expression vector also contains the pMB1 origin of replication and a kanamycin resistance gene.
- the resulting plasmid was transformed first into E. coli DH-10B, using standard methods known in the art. The transformants were isolated by subjecting the cells to kanamycin selection, as known in the art (See, e.g., US Pat. No. 8,383,346 and W02010/144103, both of which are incorporated by reference herein, in their entirety), and the sequence of the pro-Tgase gene was verified by Sanger sequencing.
- the plasmid was recovered from a positive clone, using methods known in the art, and transformed into E. coli BL21 (DE3) for expression.
- Cells were harvested by centrifugation at 8000 x g for up to 60 minutes. The supernatant was discarded, and the pellet was resuspended to 20% w/v in 50 mM tris(hydroxymethyl)aminomethane (Tris) HCI, pH 8. The cells were lysed using a high- pressure homogenizer at pressures from 15000-20000 psi. The crude lysates were clarified through centrifugation at 15000 x g for up to 60 minutes.
- Tris tris(hydroxymethyl)aminomethane
- the clarified lysate containing pro- Tgase was assessed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS- PAGE), by spectroscopy, and Tgase activity (as described in Example 1).
- Results depicted in Figure 1 show that the zymogen of a Tgase, i.e., pro-Tgase, was expressed in E.coli.
- the pro-Tgase may be secreted, for example, from a microbial strain that is known to those skilled in the art to secrete Tgase such as Streptomyces mobaraensis or Bacillus subtilis. The pellet is discarded, and the supernatant is recovered and assessed by SDS-PAGE, by spectroscopy, and activity (as described in Example 1 above).
- Clarified lysate containing pro-Tgase obtained as described in Example 2 above, was treated with a panel of commercially available immobilized proteases (Chiralvision Immozyme Protease Kit containing 20 immobilized proteases, Product Number: IMMPROT- 2000).
- the protease treated clarified lysates were incubated with shaking at 30-45 °C, pH 5- 8, for 0.1-24 hours. Protease loading was varied and optimized to deliver maximum activity within the fastest time.
- the protease-treated enzymes were compared on an SDS-PAGE gel, by spectroscopy, and by activity (as described in Example 1 above) for active enzyme.
- the products of activations described in Examples 3, 4, and 5 were analyzed using SDS- PAGE gels to visualize the ratio of Pro-Tgase to the active form of Tgase.
- Results are set forth in Table 1 and show relative activity of activated pro-Tgase (fold increase over activity of expressed zymogen, which may have some native activation during cell culture).
- Clarified lysate containing pro-Tgase was treated with either immobilized Protex® 30L (Multifect ®PR 30L); or immobilized Protex® 40L (Optimase® PR 40L) (Chiralvision; Product Numbers: IMMP30-COV-2, IMMP40-COV-2, respectively).
- the protease-treated clarified lysates were incubated with shaking at 30 or 45 °C, pH 5-9 for 0.1-24 hours. Protease loading was varied and optimized to deliver maximum activity within the fastest time.
- the protease treated enzymes were compared on an SDS- PAGE gel, by spectroscopy, and by activity (as described in Example 1) for active enzyme. Results are shown in Table 2.
- Example 5 Substrate Specificity of Activated Pro-Tgase Using Immobilized Protease [0081] Clarified lysate containing Pro-Tgase was prepared as described in Example 2.
- the lysate was diluted to a final concentration of 0.5-3 g/L Pro-Tgase at pH 5-8 using bis-tris propane, phosphate, tris-acetate, or similar buffer.
- a sample of 5-30 mg of immobilized protease was added to a 0.75 mL glass vial. Then, 0.4-0.6 mL of the buffered the lysate was added.
- a total of 22 immobilized proteases (Chiralvision Immozyme Protease Kit containing 22 immobilized proteases, Product Number: IMMPROT-2200) were tested. The mixture was incubated at 30-45°C, while mixing at 200-400 rpm. Product was sampled at time points from 0.1-24 hours for further testing.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
L'invention concerne des procédés d'activation de zymogènes de transglutaminases impliquant l'utilisation d'au moins une protéase immobilisée ainsi que des transglutaminases activées fabriquées selon de tels procédés.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163159313P | 2021-03-10 | 2021-03-10 | |
US63/159,313 | 2021-03-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022192529A1 true WO2022192529A1 (fr) | 2022-09-15 |
Family
ID=81308435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2022/019738 WO2022192529A1 (fr) | 2021-03-10 | 2022-03-10 | Activation de zymogènes par des enzymes protéases immobilisées |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2022192529A1 (fr) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993015234A1 (fr) * | 1992-01-22 | 1993-08-05 | Novo Nordisk A/S | Facteur xiii active |
WO2010144103A1 (fr) | 2009-06-11 | 2010-12-16 | Codexis, Inc. | Synthèse en parallèle automatisée combinée de variants polynucléotidique |
WO2011133704A2 (fr) * | 2010-04-20 | 2011-10-27 | Whitehead Institute For Biomedical Researh | Protéines et polypeptides modifiés et leurs utilisations |
US8383346B2 (en) | 2008-06-13 | 2013-02-26 | Codexis, Inc. | Combined automated parallel synthesis of polynucleotide variants |
WO2016170447A1 (fr) | 2015-04-24 | 2016-10-27 | Rinat Neuroscience Corp. | Transglutaminases microbiennes recombinantes |
WO2019094301A1 (fr) | 2017-11-07 | 2019-05-16 | Codexis, Inc. | Variants de transglutaminase |
-
2022
- 2022-03-10 WO PCT/US2022/019738 patent/WO2022192529A1/fr unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993015234A1 (fr) * | 1992-01-22 | 1993-08-05 | Novo Nordisk A/S | Facteur xiii active |
US8383346B2 (en) | 2008-06-13 | 2013-02-26 | Codexis, Inc. | Combined automated parallel synthesis of polynucleotide variants |
WO2010144103A1 (fr) | 2009-06-11 | 2010-12-16 | Codexis, Inc. | Synthèse en parallèle automatisée combinée de variants polynucléotidique |
WO2011133704A2 (fr) * | 2010-04-20 | 2011-10-27 | Whitehead Institute For Biomedical Researh | Protéines et polypeptides modifiés et leurs utilisations |
WO2016170447A1 (fr) | 2015-04-24 | 2016-10-27 | Rinat Neuroscience Corp. | Transglutaminases microbiennes recombinantes |
WO2019094301A1 (fr) | 2017-11-07 | 2019-05-16 | Codexis, Inc. | Variants de transglutaminase |
Non-Patent Citations (9)
Title |
---|
FOLKCOLE, J BIOL CHEMISTRY, vol. 240, no. 7, 1965, pages 2951 - 2960 |
HALEMARHAM: "THE HARPER COLLINS DICTIONARY OF BIOLOGY", 1991, HARPER PERENNIAL |
KANAJI ET AL., J. BIOL. CHEM., vol. 268, no. 16, 1993, pages 11565 - 11572 |
MARX C K ET AL: "Purification and activation of a recombinant histidine-tagged pro-transglutaminase after soluble expression in Escherichia coli and partial characterization of the active enzyme", ENZYME AND MICROBIAL TECHNOLOGY, STONEHAM, MA, US, vol. 42, no. 7, 5 June 2008 (2008-06-05), pages 568 - 575, XP022635369, ISSN: 0141-0229, [retrieved on 20080314], DOI: 10.1016/J.ENZMICTEC.2008.03.003 * |
MING-TE YANG ET AL: "Crystal Structure and Inhibition Studies of Transglutaminase from Streptomyces mobaraense*", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 286, no. 9, 4 March 2011 (2011-03-04), pages 7301 - 7307, XP055857780, DOI: 10.1074/jbc.M110.203315 * |
NAVEED MUHAMMAD ET AL: "Protease-A Versatile and Ecofriendly Biocatalyst with Multi-Industrial Applications: An Updated Review", CATALYSIS LETTERS, vol. 151, no. 2, 11 July 2020 (2020-07-11), pages 307 - 323, XP037366385, ISSN: 1011-372X, DOI: 10.1007/S10562-020-03316-7 * |
PASTERNACK ET AL: "Bacterial pro-transglutaminase from Streptoverticillium mobarense", EUROPEAN JOURNAL OF BIOCHEMISTRY, PUBLISHED BY SPRINGER-VERLAG ON BEHALF OF THE FEDERATION OF EUROPEAN BIOCHEMICAL SOCIETIES, vol. 257, 1 January 1998 (1998-01-01), pages 570 - 576, XP002127089, ISSN: 0014-2956, DOI: 10.1046/J.1432-1327.1998.2570570.X * |
SINGLETON ET AL.: "DICTIONARY OF MICROBIOLOGY AND MOLECULAR BIOLOGY", 1994, JOHN WILEY AND SONS |
ZHANG DONGXU ET AL: "Microbial transglutaminase production: understanding the mechanism", BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, INTERCEPT LTD., ANDOVER, GB, vol. 26, 1 January 2010 (2010-01-01), pages 205 - 221, XP009190210, ISSN: 0264-8725 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7795382B2 (en) | Peptide tags for the expression and purification of bioactive peptides | |
Sousa et al. | A novel metalloprotease from Bacillus cereus for protein fibre processing | |
US8748399B2 (en) | Acid-cleavable linkers exhibiting altered rates of acid hydrolysis | |
US7794979B2 (en) | Solubility tags for the expression and purification of bioactive peptides | |
CN112048009A (zh) | 用于制备经蛋白水解处理的多肽的方法 | |
CN103282016A (zh) | 用于递送使用过乙酸的脱毛剂产品底物的含水稳定组合物 | |
US8617843B2 (en) | Recombinant peptide production using a cross-linkable solubility tag | |
Kuo et al. | Purification and characterization of a thermostable keratinase from Meiothermus sp. I40 | |
US7829311B2 (en) | Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate | |
CN101918551B (zh) | 草酸脱羧酶的生产中利用的重组表达质粒载体及重组菌、以及重组草酸脱羧酶的生产方法 | |
US20040162417A1 (en) | Protease, a gene therefor and the use thereof | |
EP4211233A2 (fr) | Compositions et leurs procédés d'utilisation | |
Goshev et al. | Characterization of the enzyme complexes produced by two newly isolated thermophylic actinomycete strains during growth on collagen-rich materials | |
Cheng et al. | Purification and characterization of an eggshell membrane decomposing protease from Pseudomonas aeruginosa strain ME-4 | |
Clark et al. | Purification and characterization of a unique alkaline elastase from Micrococcus luteus | |
WO2022192529A1 (fr) | Activation de zymogènes par des enzymes protéases immobilisées | |
US7998702B2 (en) | Mutant arabinose promoter for inducible gene expression | |
Stepanov | Carboxypeptidase T | |
Goodfellow et al. | Characterization of a maize root proteinase | |
US20240093162A1 (en) | Immobilized proteases for activation of the zymogen form of transglutaminase | |
Chauhan et al. | Production and partial purification of collagenase from Bacillus sp. isolated from soil sample | |
WO2024054236A1 (fr) | Protéases immobilisées pour l'activation de la forme zymogène de la transglutaminase | |
Mikhailova et al. | Isolation and characterization of a subtilisin-like proteinase of Bacillus intermedius secreted by the Bacillus subtilis recombinant strain AJ73 at different growth stages | |
Jankiewicz et al. | An activated by cobalt alkaline aminopeptidase from Bacillus mycoides | |
Thu et al. | STUDIES ON A NOVEL RECOMBINANT LIPASE A FROM BACILLUS SUBTILIS FS2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22716609 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 23.01.2024) |